Global Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Regional Outlook and Forecast, 2024 - 2031

Global Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Regional Outlook and Forecast, 2024 - 2031

The Global Vendor Neutral Archive (VNA) & PACS Market size is expected to reach $8.3 billion by 2031, rising at a market growth of 9.3% CAGR during the forecast period.

In 2023, the Europe region generated 29% revenue share in the market. The European Union is working towards creating the European Health Data Space to improve data sharing and interoperability across member states. VNA systems are crucial for achieving the interoperability required for such initiatives by providing a standardized platform for managing diverse imaging data. European healthcare systems are pushing for medical imaging and data management standardization. PACS and VNA systems support this goal by enabling the integration of imaging data from various sources into a single, standardized platform.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In February, 2024, Hyland Software, Inc. announced the partnership with iTernity, a software company that enhances healthcare data storage. Their partnership integrates eternity iCAS FS with Hyland Healthcare's Acuo VNA, an advanced platform consolidating imaging data from various sources into a unified repository, supporting DICOM and multimedia formats for seamless integration. Moreover, In October, 2022, GE HealthCare Technologies, Inc. teamed up with Tribune Health, a Software company to enhance digital pathology with integrated solutions. The collaboration aims to merge Tribun’s Health Suite data with GE’s VNA, Edison Catalog, for a comprehensive patient record. This integration will improve pathology report accuracy, speed up diagnoses, and foster collaboration in oncology.

COVID 19 Impact Analysis

During the COVID-19 pandemic, the global supply chains for VNA and PACS systems experienced significant disruptions. Lockdowns, travel restrictions, and logistical challenges led to delays in delivering critical hardware components and system parts, affecting the ability to deploy and maintain these systems. Many VNA and PACS, hardware manufacturing facilities, faced temporary closures or reduced operations due to COVID-19. This resulted in delays in production schedules and supply shortages, impacting the availability of necessary components for system implementation. Thus, the COVID-19 pandemic had a negative impact on the market.

Market Growth Factors

Healthcare organizations increasingly seek unified platforms that allow for centralized medical data management. VNA solutions can store and manage imaging data from various modalities and departments in a single, accessible repository. This integration supports seamless data access and management across different healthcare settings, critical for comprehensive patient care. In conclusion, the rising demand for integrated healthcare systems and solutions drives the market's growth.

Additionally, Healthcare providers are using a variety of imaging modalities (e.g., MRI, CT scans, X-rays), each producing data in different formats. VNAs offer a standardized platform for storing and managing data from these diverse modalities, enabling seamless integration and access across different systems. This integration is crucial for ensuring that imaging data can be easily accessed and interpreted regardless of the source. Therefore, the growing need for interoperability and data sharing propels the market's growth.

Market Restraining Factors

VNA and PACS systems deployment requires substantial capital expenditure for hardware, software, and infrastructure. High-performance servers, storage systems, and network infrastructure are needed to support the complex requirements of these systems. The costs associated with acquiring and maintaining this infrastructure can be prohibitive, especially for smaller healthcare facilities and organizations. In conclusion, VNA and PACS solutions' high initial costs and implementation challenges are hindering the market's growth.

Product Type Outlook

Based on product type, the market is divided into VNA and PACS. In 2023, the PACS segment attained 43% revenue share in the market. Picture Archiving and Communication Systems (PACS) provide a centralized repository for medical imaging data. This centralization ensures that imaging data from various modalities and sources are stored in one location, making it easier for healthcare professionals to access and manage patient images.

Vendor Type Outlook

By vendor type, the market is divided into independent vendors and third-party vendors. The third-party vendor segment procured 40% revenue share in the market in 2023. Third-party vendors provide VNA and PACS solutions agnostic to specific imaging equipment or software providers. This neutrality allows for seamless integration with various existing systems from different manufacturers, enabling healthcare organizations to consolidate and manage their imaging data more effectively.

Deployment Outlook

Based on deployment mode, the market is categorized into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment registered 32% revenue share in the market. Cloud-based solutions offer exceptional scalability, allowing healthcare organizations to expand their storage capacities in response to the increasing volumes of imaging data. This scalability ensures that cloud-based VNA and PACS systems can efficiently accommodate growing data needs without requiring significant upfront investment in physical infrastructure.

End User Outlook

On the basis of end user, the market is divided into hospitals & clinics, diagnostic centers, and others. The diagnostic centers segment held 21% revenue share in the market in 2023. Diagnostic centers increasingly rely on advanced imaging technologies and data management systems to enhance their services and improve patient care. The integration of VNA and PACS solutions enables these facilities to streamline their operations, facilitate collaboration with hospitals, and provide timely diagnostic insights.

Application Outlook

Based on application, the market is divided into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and others. The oncology segment attained 22% revenue share in the market in 2023. Oncology involves using various imaging modalities, such as PET, CT, MRI, and ultrasound, to diagnose, stage, and monitor cancer. VNA and PACS systems are crucial for integrating these diverse imaging formats into a unified system, enabling comprehensive management and review of patient data across multiple modalities.

Modality Outlook

On the basis of modality, the market is segmented into computed tomography, mammography, MRI, ultrasound, X-rays, and PET. In 2023, the X-rays segment attained 22% revenue share in the market. X-ray imaging remains one of healthcare's most frequently used diagnostic tools due to its effectiveness in detecting various conditions, from fractures to infections. Daily, the high volume of X-ray images generated drives significant demand for storage and management solutions, such as VNA and PACS. X-rays are utilized in routine and emergency settings, making them a staple in medical imaging.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 39% revenue share in the market in 2023. North America, particularly the United States and Canada, boasts a highly advanced and sophisticated healthcare infrastructure. This development creates a robust environment for adopting advanced imaging solutions like VNA and PACS, integral to modern healthcare delivery. The healthcare sector in North America is quick to adopt new technologies.

Recent Strategies Deployed in the Market

• Feb-2024: Fujifilm Holdings Corporation unveiled Synapse VNA and Synapse Radiology PACS have been ranked #1 in the 2024 Best in KLAS Awards: Software and Services. This recognition highlights their excellence in diagnostic and enterprise imaging, helping healthcare organizations manage imaging data and enhance patient care across the healthcare ecosystem.
• Nov-2023: Hyland Software, Inc. unveiled its advanced diagnostic imaging and point-of-care solutions at this year’s RSNA conference. The company aims to address healthcare challenges like staff shortages and increasing demand by offering technologies that enhance patient information and decision-making.
• Feb-2023: Fujifilm Holdings Corporation announced the acquisition of Inspirata’s global digital pathology business, including the Dynamyx system. This acquisition strengthens Fujifilm’s healthcare capabilities, enhancing collaboration between pathology, radiology, and oncology, and improving integrated care delivery across the enterprise. Inspirata is a Tampa-based company specializing in cancer informatics.
• Sep-2022: IBM Corporation unveiled data, analytics, and technology solutions for the health industry. Their Enterprise Imaging solutions include IBM iConnect Access, a zero-download image viewer, IBM iConnect Enterprise Archive, a VNA, and Merge PACS, an AI-ready workflow platform.
• Apr-2022: Koninklijke Philips N.V. teamed up with Prisma Health, an 814-bed tertiary referral hospital and academic center to enhance enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions. This collaboration aims to improve patient care, and clinical performance, and achieve the quadruple aim: better satisfaction, lower costs, and enhanced outcomes for South Carolinians.

List of Key Companies Profiled

• Hyland Software, Inc.
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Siemens Healthineers AG (Siemens AG)
• Fujifilm Holdings Corporation
• IBM Corporation
• Carestream Health, Inc. (Onex Corporation)
• Novarad Enterprise Healthcare Solutions
• Canon, Inc. (Canon Medical Systems Corporation)
• INFINITT Healthcare Co. Ltd.

Global Vendor Neutral Archive (VNA) & PACS Market Report Segmentation

By Product Type

• VNA
• Multi-Department VNA
• Department VNA
• Multi-Site VNA
• PACS
• Multi-Department PACS
• Department PACS
• Multi-Site PACS

By Vendor Type

• Independent Vendor
• Third-party Vendor

By Deployment

• On-Premise
• Cloud-Based
• Hybrid Model

By End User

• Hospitals & Clinics
• Diagnostic Centers
• Others

By Application

• Cardiology
• Orthopedic
• Oncology
• Neurology
• Obstetrics & Gynecology
• Others

By Modality

• Computed Tomography
• Mammography
• MRI
• Ultrasound
• X-Rays
• PET

By Geography

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA